Circulating immune complexes in old people and in diabetics: correlation with autoantibodies. 1980

G Delespesse, and P Gausset, and M Sarfati, and M Dubi-Rucquoy, and M J Debisschop, and L van Haelst

Circulating immune complexes (CIC) were detected by a solid-phase radioassay in 34% of fifty-three insulin-dependent diabetics (IDD) as compared to 18% of forty-five non-insulin-dependent diabetics (NIDD) and 14% of 173 control subjects. In control subjects, the prevalence of CIC increased with age and was higher in males than in females. In IDD, immune complexes were found with the highest frequency before the age of 30 and after 50. There was no significant difference between the incidence of CIC in old IDD and their age-matched controls. The same sera were also tested for the presence of the following autoantibodies; nuclear , thyroid, gastric, smooth and striated muscle; mitochondria, sub-maxillary and adrenal gland and liver-kidney microsome. Sera containing at least one antibody were found in 16.4% of controls, 55.3% of IDD and 40% of NIDD. The prevalence of autoantibodies increased with age in controls but not in IDD. Islet cell antibodies were present in 28.5% of IDD and 2.9% of control subjects; they were more frequent in young patients. CIC and autoantibodies were statistically associated both in controls and IDD; in the patients, CIC were associated not only with islet cell antibodies but also with other autoantibodies. The possible relation between autoimmunity, degenerative vascular diseases and CIC is discussed.

UI MeSH Term Description Entries
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody

Related Publications

G Delespesse, and P Gausset, and M Sarfati, and M Dubi-Rucquoy, and M J Debisschop, and L van Haelst
January 1985, Yonsei medical journal,
G Delespesse, and P Gausset, and M Sarfati, and M Dubi-Rucquoy, and M J Debisschop, and L van Haelst
August 1983, Allergy,
G Delespesse, and P Gausset, and M Sarfati, and M Dubi-Rucquoy, and M J Debisschop, and L van Haelst
June 1983, Clinical and experimental immunology,
G Delespesse, and P Gausset, and M Sarfati, and M Dubi-Rucquoy, and M J Debisschop, and L van Haelst
August 1990, Parassitologia,
G Delespesse, and P Gausset, and M Sarfati, and M Dubi-Rucquoy, and M J Debisschop, and L van Haelst
March 1981, British journal of cancer,
G Delespesse, and P Gausset, and M Sarfati, and M Dubi-Rucquoy, and M J Debisschop, and L van Haelst
November 1984, Vrachebnoe delo,
G Delespesse, and P Gausset, and M Sarfati, and M Dubi-Rucquoy, and M J Debisschop, and L van Haelst
January 1986, Oftalmologicheskii zhurnal,
G Delespesse, and P Gausset, and M Sarfati, and M Dubi-Rucquoy, and M J Debisschop, and L van Haelst
January 1988, Medical microbiology and immunology,
G Delespesse, and P Gausset, and M Sarfati, and M Dubi-Rucquoy, and M J Debisschop, and L van Haelst
June 1982, Journal of clinical & laboratory immunology,
G Delespesse, and P Gausset, and M Sarfati, and M Dubi-Rucquoy, and M J Debisschop, and L van Haelst
January 1997, The National medical journal of India,
Copied contents to your clipboard!